• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β诱导蛋白(TGFBI)/(βig-H3):一种在卵巢癌中具有双重功能的基质蛋白。

Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.

作者信息

Ween Miranda P, Oehler Martin K, Ricciardelli Carmela

机构信息

Discipline of Obstetrics and Gynaecology, School of Paediatrics and Reproductive Health, Research Centre for Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, South Australia, 5000, Australia.

Research Centre for Infectious Diseases, School of Molecular Biosciences, University of Adelaide, South Australia 5005, Australia.

出版信息

Int J Mol Sci. 2012;13(8):10461-10477. doi: 10.3390/ijms130810461. Epub 2012 Aug 21.

DOI:10.3390/ijms130810461
PMID:22949874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3431872/
Abstract

Transforming growth factor-beta-induced protein (TGFBI, also known as βig-H3 and keratoepithelin) is an extracellular matrix protein that plays a role in a wide range of physiological and pathological conditions including diabetes, corneal dystrophy and tumorigenesis. Many reports indicate that βig-H3 functions as a tumor suppressor. Loss of βig-H3 expression has been described in several cancers including ovarian cancer and promoter hypermethylation has been identified as an important mechanism for the silencing of the TGFBI gene. Our recent findings that βig-H3 is down-regulated in ovarian cancer and that high concentrations of βig-H3 can induce ovarian cancer cell death support a tumor suppressor role. However, there is also convincing data in the literature reporting a tumor-promoting role for βig-H3. We have shown βig-H3 to be abundantly expressed by peritoneal cells and increase the metastatic potential of ovarian cancer cells by promoting cell motility, invasion, and adhesion to peritoneal cells. Our findings suggest that βig-H3 has dual functions and can act both as a tumor suppressor or tumor promoter depending on the tumor microenvironment. This article reviews the current understanding of βig-H3 function in cancer cells with particular focus on ovarian cancer.

摘要

转化生长因子-β诱导蛋白(TGFBI,也称为βig-H3和角膜上皮素)是一种细胞外基质蛋白,在包括糖尿病、角膜营养不良和肿瘤发生在内的多种生理和病理状况中发挥作用。许多报告表明,βig-H3起着肿瘤抑制因子的作用。在包括卵巢癌在内的几种癌症中都描述了βig-H3表达的缺失,并且启动子高甲基化已被确定为TGFBI基因沉默的重要机制。我们最近的研究结果表明,βig-H3在卵巢癌中表达下调,并且高浓度的βig-H3可诱导卵巢癌细胞死亡,这支持了其肿瘤抑制作用。然而,文献中也有令人信服的数据报道βig-H3具有促肿瘤作用。我们已经表明,βig-H3在腹膜细胞中大量表达,并通过促进细胞运动、侵袭以及与腹膜细胞的黏附来增加卵巢癌细胞的转移潜能。我们的研究结果表明,βig-H3具有双重功能,并且根据肿瘤微环境的不同,它既可以作为肿瘤抑制因子,也可以作为肿瘤促进因子。本文综述了目前对βig-H3在癌细胞中功能的理解,尤其侧重于卵巢癌。

相似文献

1
Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.转化生长因子-β诱导蛋白(TGFBI)/(βig-H3):一种在卵巢癌中具有双重功能的基质蛋白。
Int J Mol Sci. 2012;13(8):10461-10477. doi: 10.3390/ijms130810461. Epub 2012 Aug 21.
2
Matrix metalloproteinase 9 (MMP-9)-dependent processing of βig-h3 protein regulates cell migration, invasion, and adhesion.基质金属蛋白酶 9(MMP-9)依赖的βig-h3 蛋白的加工调节细胞迁移、侵袭和黏附。
J Biol Chem. 2012 Nov 9;287(46):38957-69. doi: 10.1074/jbc.M112.357863. Epub 2012 Sep 27.
3
Epigenetic inactivation of Betaig-h3 gene in human cancer cells.人类癌细胞中Betaig-h3基因的表观遗传失活
Cancer Res. 2006 May 1;66(9):4566-73. doi: 10.1158/0008-5472.CAN-05-2130.
4
Tumor suppressor function of Betaig-h3 gene in radiation carcinogenesis.Betaig-h3基因在辐射致癌中的肿瘤抑制功能
Adv Space Res. 2003;31(6):1575-82. doi: 10.1016/s0273-1177(03)00094-2.
5
βig-h3 supports gastric cancer cell adhesion, migration and proliferation in peritoneal carcinomatosis.βig-h3 促进腹膜转移胃癌细胞的黏附、迁移和增殖。
Mol Med Rep. 2012 Sep;6(3):558-64. doi: 10.3892/mmr.2012.951. Epub 2012 Jun 15.
6
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.细胞外基质蛋白βig-h3/TGFBI通过增强细胞外渗促进结肠癌转移。
Genes Dev. 2008 Feb 1;22(3):308-21. doi: 10.1101/gad.1632008.
7
Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.蛋白质组学鉴定β ig-h3 为人间质干细胞中脂酰磷酸诱导的分泌蛋白:β ig-h3 对 A549 肺腺癌细胞的旁分泌激活。
Mol Cell Proteomics. 2012 Feb;11(2):M111.012385. doi: 10.1074/mcp.M111.012385. Epub 2011 Dec 7.
8
Induction and expression of betaig-h3 in pancreatic cancer cells.βig-h3在胰腺癌细胞中的诱导与表达
Biochim Biophys Acta. 2002 Oct 9;1588(1):1-6. doi: 10.1016/s0925-4439(02)00052-2.
9
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.β3 整合素调节转化生长因子β诱导(TGFBI)功能和紫杉醇在卵巢癌细胞中的反应。
Mol Cancer. 2012 May 28;11:36. doi: 10.1186/1476-4598-11-36.
10
BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.βIg-h3参与人肝癌细胞中HAb18G/CD147介导的转移过程。
Exp Biol Med (Maywood). 2007 Mar;232(3):344-52.

引用本文的文献

1
Mass Spectrometric Analysis of Clomiphene Citrate-induced Changes in the Secretome Profile of PAX8-positive Human Fallopian Tube Secretory Epithelial Cells and Identification of Biomarkers Relevant to Reproduction and Pregnancy.枸橼酸氯米芬诱导的PAX8阳性人输卵管分泌上皮细胞分泌组谱变化的质谱分析及与生殖和妊娠相关生物标志物的鉴定。
Reprod Sci. 2025 Jun 11. doi: 10.1007/s43032-025-01884-w.
2
Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma.β-胰岛细胞素H3(βigH3/TGFBI)的蛋白水解降解可在血清中进行非侵入性定量,并预测晚期胰腺导管腺癌患者的预后。
BMC Cancer. 2025 May 20;25(1):905. doi: 10.1186/s12885-025-14283-w.
3

本文引用的文献

1
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.β3 整合素调节转化生长因子β诱导(TGFBI)功能和紫杉醇在卵巢癌细胞中的反应。
Mol Cancer. 2012 May 28;11:36. doi: 10.1186/1476-4598-11-36.
2
Human U87 astrocytoma cell invasion induced by interaction of βig-h3 with integrin α5β1 involves calpain-2.人 U87 星形细胞瘤细胞的侵袭由βig-h3 与整合素 α5β1 的相互作用诱导,涉及钙蛋白酶-2。
PLoS One. 2012;7(5):e37297. doi: 10.1371/journal.pone.0037297. Epub 2012 May 21.
3
Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.
Reassessing the Role of Tissue Factor Pathway Inhibitor 2 in Neoplastic and Non-Neoplastic Lesions.重新评估组织因子途径抑制物2在肿瘤性和非肿瘤性病变中的作用
Cancers (Basel). 2025 Apr 25;17(9):1447. doi: 10.3390/cancers17091447.
4
TGFBI regulates the TGF-β pathway to affect the malignant progression and cisplatin sensitivity in diffuse large B-cell lymphoma.转化生长因子β诱导蛋白(TGFBI)调节转化生长因子-β(TGF-β)信号通路,影响弥漫性大B细胞淋巴瘤的恶性进展和顺铂敏感性。
Ann Hematol. 2025 Feb;104(2):1165-1176. doi: 10.1007/s00277-025-06208-1. Epub 2025 Jan 25.
5
miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed mice.微小RNA-21:高脂饮食喂养小鼠中延缓严重肝病和肝细胞癌的治疗靶点
bioRxiv. 2024 Oct 5:2024.09.19.613915. doi: 10.1101/2024.09.19.613915.
6
Current data and future perspectives on DNA methylation in ovarian cancer (Review).当前关于卵巢癌中 DNA 甲基化的研究数据和未来展望(综述)。
Int J Oncol. 2024 Jun;64(6). doi: 10.3892/ijo.2024.5650. Epub 2024 May 17.
7
Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics.基于血浆蛋白质组学的孟德尔随机化分析确定失眠的潜在药物靶点
Front Neurol. 2024 Apr 25;15:1380321. doi: 10.3389/fneur.2024.1380321. eCollection 2024.
8
Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis.综合分析确定TGFBI作为脓毒症患者疾病严重程度和与免疫浸润相关预后的生物标志物。
J Inflamm Res. 2024 Apr 15;17:2285-2298. doi: 10.2147/JIR.S456132. eCollection 2024.
9
The coordinated activities of collagen VI and XII in maintenance of tissue structure, function and repair: evidence for a physical interaction.胶原蛋白VI和XII在维持组织结构、功能及修复中的协同作用:物理相互作用的证据
Front Mol Biosci. 2024 Mar 28;11:1376091. doi: 10.3389/fmolb.2024.1376091. eCollection 2024.
10
Chloride Intracellular Channel Protein 1 (CLIC1) Is a Critical Host Cellular Factor for Influenza A Virus Replication.氯离子细胞内通道蛋白 1(CLIC1)是流感 A 病毒复制的关键宿主细胞因子。
Viruses. 2024 Jan 16;16(1):129. doi: 10.3390/v16010129.
转化生长因子 β 诱导(TGFBI)是一种抗黏附蛋白,调节黑色素瘤细胞的浸润生长。
Am J Pathol. 2012 Apr;180(4):1663-74. doi: 10.1016/j.ajpath.2011.12.035. Epub 2012 Feb 9.
4
Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia.子痫前期妇女尿中nephrin、podocalyxin 和 βig-h3 的排泄增加。
Am J Physiol Renal Physiol. 2012 May 1;302(9):F1084-9. doi: 10.1152/ajprenal.00597.2011. Epub 2012 Feb 1.
5
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.TGFBI 启动子超甲基化与卵巢癌紫杉醇化疗耐药相关。
J Exp Clin Cancer Res. 2012 Jan 16;31(1):6. doi: 10.1186/1756-9966-31-6.
6
Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.蛋白质组学鉴定β ig-h3 为人间质干细胞中脂酰磷酸诱导的分泌蛋白:β ig-h3 对 A549 肺腺癌细胞的旁分泌激活。
Mol Cell Proteomics. 2012 Feb;11(2):M111.012385. doi: 10.1074/mcp.M111.012385. Epub 2011 Dec 7.
7
Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma.鉴定人胰腺导管腺癌中具有诊断和治疗潜力的新型可及蛋白。
J Proteome Res. 2011 Sep 2;10(9):4302-13. doi: 10.1021/pr200527z. Epub 2011 Jul 29.
8
Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.转化生长因子-β诱导蛋白(TGFBI)通过 Akt/mTOR 通路抑制间皮瘤进展。
Int J Oncol. 2011 Oct;39(4):1001-9. doi: 10.3892/ijo.2011.1097. Epub 2011 Jun 23.
9
TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells.TGFBI 表达降低了肺和乳腺肿瘤细胞的体外和体内转移潜能。
Cancer Lett. 2011 Sep 1;308(1):23-32. doi: 10.1016/j.canlet.2011.04.010. Epub 2011 May 10.
10
MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3.miR-21 通过直接靶向肿瘤抑制基因 Big-h3 在 BALB/c 小鼠的辐射诱导致癌中发挥重要作用。
Int J Biol Sci. 2011 Apr 1;7(3):347-63. doi: 10.7150/ijbs.7.347.